Publication: Relationship between interleukin-8 and the oxidant-antioxidant system in end-stage renal failure patients
| dc.contributor.authors | Aydin, Makbule; Ozkok, Elif; Ozturk, Oguz; Agachan, Bedia; Yilmaz, Hulya; Yaylim, Ilhan; Kebabcioglu, Seher; Ispir, Turgay | |
| dc.date.accessioned | 2022-03-12T17:32:46Z | |
| dc.date.accessioned | 2026-01-11T15:10:54Z | |
| dc.date.available | 2022-03-12T17:32:46Z | |
| dc.date.issued | 2007 | |
| dc.description.abstract | Objectives: We aimed to evaluate the relationship between interleukin-8 and the oxidant-antioxidant system in end-stage renal failure patients with and without diabetes mellitus undergoing regular hemodialysis treatment. Materials and Methods: Plasma levels of malondialdehyde and whole blood reduced glutathione were measured as markers of the oxidant and antioxidant systems, respectively. Plasma interleukin-8 levels were measured by enzyme-linked immunosorbent assay. Results: When compared with controls, plasma interleukin-8 levels were elevated in both diabetic and nondiabetic end-stage renal disease patients. Plasma malondialdehyde levels were statistically significantly higher in end-stage renal disease patients with and without diabetes mellitus than they were in controls; however, reduced glutathione levels were statistically significantly lower in diabetic and nondiabetic end-stage renal disease patients than they were controls. Conclusions: In end-stage renal disease patients with and without diabetes mellitus, elevated interleukin-8 levels and decreased reduced glutathione levels may be attributed to increased oxidative stress due to inflammation. In other words, increased reactive oxygen species may induce interleukin-8 production and result in diminished reduced glutathione levels. Our data suggest a relationship between interleukin-8 and the oxidant-antioxidant system in end-stage renal failure patients. | |
| dc.identifier.doi | doiWOS:000254720600008 | |
| dc.identifier.issn | 1304-0855 | |
| dc.identifier.pubmed | 17617053 | |
| dc.identifier.uri | https://hdl.handle.net/11424/228686 | |
| dc.identifier.wos | WOS:000254720600008 | |
| dc.language.iso | eng | |
| dc.publisher | BASKENT UNIV | |
| dc.relation.ispartof | EXPERIMENTAL AND CLINICAL TRANSPLANTATION | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | cytokine | |
| dc.subject | malondialdehyde | |
| dc.subject | glutathione | |
| dc.subject | NF-KAPPA-B | |
| dc.subject | TRANSCRIPTION FACTORS AP-1 | |
| dc.subject | NECROSIS-FACTOR-ALPHA | |
| dc.subject | EPITHELIAL-CELLS | |
| dc.subject | DIFFERENTIAL ACTIVATION | |
| dc.subject | OXIDATIVE STRESS | |
| dc.subject | GLUTATHIONE | |
| dc.subject | KIDNEY | |
| dc.subject | INFLAMMATION | |
| dc.subject | EXPRESSION | |
| dc.title | Relationship between interleukin-8 and the oxidant-antioxidant system in end-stage renal failure patients | |
| dc.type | article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 613 | |
| oaire.citation.issue | 1 | |
| oaire.citation.startPage | 610 | |
| oaire.citation.title | EXPERIMENTAL AND CLINICAL TRANSPLANTATION | |
| oaire.citation.volume | 5 |
